Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-24

FDA Approved: ACZONE — Original Application (Almirall, LLC)

View source ↗

Summary

The FDA approved Aczone (dapsone) topical gel 5% for the treatment of acne vulgaris in patients 12 years and older. This submission represents the original NDA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACZONE (DAPSONE)

Snippet

ORIG AP for ACZONE (DAPSONE)